According to a recent report by CIDRAP and the CDC, published on November 24, 2025, viral activity is on the rise, and it's ...
The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...
FDA reexamine infant RSV therapies with Sanofi, AstraZeneca, and Merck amid safety concerns and data review under new FDA leadership.
It's once again the time of year for an uptick in illnesses such as colds, the flu, COVID and RSV. Here are the signs and ...
U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective ...
Discover Magazine on MSN
Mini-nose models sniff out the reasons why RSV infection turns deadly in infants
Learn what happens to cells inside the nose during an RSV infection, and why infants are so vulnerable to the virus.
The Centers for Disease Control and Prevention's vaccine advisory committee voted on Thursday to recommend infants receive a newer monoclonal antibody shot for respiratory syncytial virus (RSV). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback